NewslettersMammary Cell News MY11 Exerts Antitumor Effects through Activation of the NF-κB/PUMA Signaling Pathway in Breast Cancer By Bob - June 30, 2022 0 MY11 inhibited the growth of MDA-MB-231 and MCF-7 breast cancer cells by arresting the cell cycle and promoting apoptosis, through regulation of the cell cycle and apoptosis-related proteins. [Investigational New Drugs] Full Article